The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months.
In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...
After plugging billions into its manufacturing network to meet rampant demand for Mounjaro and Zepbound, Eli Lilly is looking ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback